Prognostic assessment of T‐cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis
International Journal of Cancer · 15.03.2025 · 156 (6) · 1282-1292
DOI: 10.1002/ijc.35252 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 07.11.2024. Verfasst von Andriy Trailin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, CD8-Positive T-Lymphocytes, T-Lymphocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentura Pro Zdravotnický Výzkum České Republiky, Czech Health Research Council.
Abstract (Originalsprache)
Prognostic value of T‐cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM ( N = 55) or metachronous LM ( N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T‐cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM. High densities of CD8+ T‐cells in TC, OM and PT of synchronous LM were associated with longer disease‐free survival (DFS). Greater densities of CD3+ T‐cells in IM and PT and CD8+ T‐cells in IM, OM and PT in synchronous LM over pCRC were associated with longer DFS. Greater densities of CD8+ T‐cells in the TC and IM and CD3+ T‐cells in the IM of pCRC were found in the metachronous over synchronous group. The first novel finding demonstrated that high density of CD8+ T cells in synchronous LM were associated with favorable outcome. The second finding of high CD8+ cell density in pCRC in metachronous over synchronous CRC may provide a mechanistic basis for the delay of metastatic spread. Both findings could be applied clinically with own reference values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
ORCID-Profile: Andriy Trailin
Förderung
- Agentura Pro Zdravotnický Výzkum České Republiky
- Czech Health Research Council
Zitieren
APA
Trailin, A., Ali, E., Ye, W., Pavlov, S., Červenková, L., Vyčítal, O., Ambrozkiewicz, F., Hošek, P., Daum, O., Liška, V., & Hemminki, K. (2025). Prognostic assessment of T‐cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis. International Journal of Cancer, 156(6), 1282-1292. https://doi.org/10.1002/ijc.35252
Vancouver
Trailin A, Ali E, Ye W, Pavlov S, Červenková L, Vyčítal O, et al. Prognostic assessment of T‐cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis. International Journal of Cancer. 2025;156(6):1282-1292. doi:10.1002/ijc.35252
BibTeX
@article{Trailin2025,
author = {Trailin, Andriy and Ali, Esraa and Ye, Wenjing and Pavlov, Sergii and Červenková, Lenka and Vyčítal, Ondřej and Ambrozkiewicz, Filip and Hošek, Petr and Daum, Ondřej and Liška, Václav and Hemminki, Kari},
title = {Prognostic assessment of T‐cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis},
journal = {International Journal of Cancer},
year = {2025},
volume = {156},
number = {6},
pages = {1282--1292},
doi = {10.1002/ijc.35252}
}
EUVIMED